Tech Company Financing Transactions
bluebird bio Funding Round
bluebird bio, operating out of Cambridge, received $12 million from Easton Capital and TVM Capital.
Transaction Overview
Company Name
Announced On
10/6/2004
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Easton Capital (John Friedman)
TVM Capital (Stephen Hoffman)
Proceeds Purpose
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
60 Binney St.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
bluebird bio is developing innovative gene therapies for severe genetic disorders. Our vision is to make the hope of gene therapy a reality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nick Leschly
Chief Financial Officer
Jeffrey Walsh
Chief Medical Officer
David Davidson
Chief Scientific Officer
Philip Gregory
Chief Technical Officer
Derek Adams
VP - Bus. Development
Joanne Smith-Farrell
VP - General Counsel
Jason Cole
VP - Human Resources
Kathy Wilkinson
Browse more venture capital transactions:
Prev: 10/5/2004: Blacksmith Applications venture capital transaction
Next: 10/7/2004: Astoria Software venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs